Bacterial DNA, RNA, and protein synthesis machinery

The bacterial DNA, RNA, and protein synthesis machinery encompasses the essential molecular complexes responsible for the central dogma of molecular biology within prokaryotic cells (NIH, 2016). This broad target category includes DNA gyrase and topoisomerase IV, which manage DNA supercoiling during replication; RNA polymerase, which transcribes genetic information into messenger RNA; and the 70S ribosome, which translates mRNA into functional proteins (StatPearls, 2023). These systems are vital for bacterial viability, growth, and reproduction, making them the most common targets for antimicrobial therapy (Lumen Learning, 2021). Selective toxicity is achieved because bacterial versions of these machines possess distinct structural features compared to human eukaryotic counterparts (NIH, 2021). For instance, fluoroquinolones inhibit DNA synthesis, rifamycins target RNA synthesis, and various classes like macrolides and tetracyclines inhibit protein synthesis by binding to ribosomal subunits (Creative Biolabs, 2024). These targets are critical in the treatment of diverse infectious diseases, ranging from simple skin infections to life-threatening conditions like pneumonia and meningitis. However, the effectiveness of drugs hitting these targets is frequently compromised by the development of resistance, including target site modifications and the upregulation of efflux pumps (NIH, 2020). Understanding the structural nuances of these machines is essential for the development of next-generation antibiotics capable of overcoming multi-drug resistance.

Other names

Bacterial macromolecular synthesis machineryBacterial central dogma machineryBacterial replication, transcription, and translation systems

Inhibition of DNA gyrase and topoisomerase IV (DNA synthesis); inhibition of DNA-dependent RNA polymerase (RNA synthesis); and binding to the 30S or 50S ribosomal subunits to prevent peptide bond formation or translocation (protein synthesis).